Copyright 2010 Medical News TodayLatest Health News and Medical News posted throughout the day, every day.http://www.medicalnewstoday.com/sections/multiple_sclerosis/admin@medicalnewstoday.com (MNT Admin)editors@medicalnewstoday.com (MNT Editors)en-us Tue, 09 Feb 2010 16:00:00 PSThttp://mnt.to/f/3xqghttp://mnt.to/f/3xqgA new study reveals that multiple sclerosis (MS) patients enrolled in a seven-month disease therapy management (DTM) program show greater adherence to injectable MS medications and treatment persistence than patients who receive injectable MS medications through a community pharmacy...Multiple Sclerosis Mon, 08 Feb 2010 03:00:00 PSThttp://mnt.to/f/3xmqhttp://mnt.to/f/3xmqJames Gray MP has argued the Risk Sharing Scheme has 'fatal flaws' and is 'hopelessly out of date'. James Gray MP, Chair of the All Party Parliamentary Group on MS, secured a debate on the Risk Sharing Scheme on Tuesday of this week. The purpose of the debate was to consider whether the Scheme has worked to benefit either people living with MS or the NHS...Multiple Sclerosis Mon, 08 Feb 2010 00:00:00 PSThttp://mnt.to/f/3xm2http://mnt.to/f/3xm2Fewer African Americans than Caucasians develop multiple sclerosis (MS), statistics show, but their disease progresses more rapidly, and they don't respond as well to therapies, a new study by neurology researchers at the University at Buffalo has found...Multiple Sclerosis Mon, 01 Feb 2010 09:00:00 PSThttp://mnt.to/f/3x48http://mnt.to/f/3x48People across England will be joining forces to demonstrate their outrage at Gordon Brown's failure to act on his promise to abolish prescription charges for people with long-term conditions, by taking part in a simultaneous 'wake-up phone call' to No 10...Respiratory / Asthma Mon, 01 Feb 2010 02:00:00 PSThttp://mnt.to/f/3x2Zhttp://mnt.to/f/3x2ZPrevious studies have shown multiple sclerosis (MS) patients are more often born in spring than in any other season, indicating that there is an environmental risk factor for the disease. A paper in the journal Neurology, reviewed for f1000 Medicine by Emmanuelle Waubant and Ellen Mowry, now suggests that this seasonal effect is mediated by the gene HLA-DRB1...Multiple Sclerosis Mon, 01 Feb 2010 01:00:00 PSThttp://mnt.to/f/3x2Jhttp://mnt.to/f/3x2JProject A.L.S. (New York, NY) and the Robert Packard Center for ALS Research at Johns Hopkins University (Baltimore, MD) announced that they will partner on P2 ALS, a $15 million initiative designed to advance ALS (Lou Gehrig's disease) research exponentially over the next three years. Project A.L.S...Multiple Sclerosis Sun, 31 Jan 2010 00:00:00 PSThttp://mnt.to/f/3wZ6http://mnt.to/f/3wZ6The MS Society has called for researchers and scientists to come forward with research projects investigating the potential benefit of stem cells in multiple sclerosis (MS). A new partnership between the MS Society and the UK Stem Cell Foundation has levered £1million to be specifically ring-fenced for translational, pre-clinical and clinical trials...Stem Cell Research Fri, 29 Jan 2010 05:00:00 PSThttp://mnt.to/f/3wYXhttp://mnt.to/f/3wYXRegis Technologies, Inc., a leading provider of cGMP and non-GMP synthesis and separations services for active pharmaceutical ingredients (APIs) and intermediates, announced it has received an Establishment Inspection Report (EIR) from the U.S...Multiple Sclerosis Tue, 26 Jan 2010 01:00:00 PSThttp://mnt.to/f/3wLkhttp://mnt.to/f/3wLkPROLOR Biotech, Inc., (OTC Bulletin Board: PBTH) reported positive results from a comparative study in primates of its longer-acting version of the multiple sclerosis drug interferon beta (IFN-beta-1a-CTP, referred to as IFN-beta-CTP)...Multiple Sclerosis Tue, 26 Jan 2010 00:00:00 PSThttp://mnt.to/f/3wKRhttp://mnt.to/f/3wKRThe US Food and Drug Administration (FDA) has approved a drug which has been found to allow people with multiple sclerosis (MS) to walk faster. People treated with the drug Ampyra (dalfampridine) were found in clinical trials to have faster walking speeds than those treated with a placebo, the American drug watchdog found...Multiple Sclerosis Tue, 26 Jan 2010 00:00:00 PSThttp://mnt.to/f/3wKShttp://mnt.to/f/3wKSThe European Medicines Agency (EMA) has finalised a review of Tysabri (natalizumab) and the risk of progressive multifocal leukoencephalopathy (PML), a rare brain infection caused by the JC virus. The Agency's Committee for Medicinal Products for Human Use (CHMP) has concluded that the risk of developing PML increases after two years of use of Tysabri although this risk remains low...Multiple Sclerosis Mon, 25 Jan 2010 05:00:00 PSThttp://mnt.to/f/3wKDhttp://mnt.to/f/3wKDElan Drug Technologies, a business unit of Elan Corporation, plc (NYSE: ELN) today issued the following statement regarding the U.S. Food and Drug Administration (FDA) approval of AMPYRA™ (dalfampridine) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA™ will be marketed in the U.S...Multiple Sclerosis Mon, 25 Jan 2010 03:00:00 PSThttp://mnt.to/f/3wKmhttp://mnt.to/f/3wKmBiogen Idec (NASDAQ: BIIB) today issued the following statement regarding the United States (U.S.) Food and Drug Administration (FDA) approval of AMPYRA™ (dalfampridine) to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. The U.S. FDA approval was granted on January 22, 2010. AMPYRA will be marketed in the U...Multiple Sclerosis Mon, 25 Jan 2010 00:00:00 PSThttp://mnt.to/f/3wJFhttp://mnt.to/f/3wJFThe Food and Drug Administration has approved the drug fampridine-SR for the treatment of multiple sclerosis...Multiple Sclerosis Sat, 23 Jan 2010 01:00:00 PSThttp://mnt.to/f/3wHLhttp://mnt.to/f/3wHLEMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany, announced the online publication of the results from the CLARITY(1) Phase III trial using Cladribine Tablets (EMD Serono's proprietary investigational oral formulation of cladribine) in The New England Journal of Medicine(2)...Multiple Sclerosis Sat, 23 Jan 2010 01:00:00 PSThttp://mnt.to/f/3wHNhttp://mnt.to/f/3wHNThe U.S. Food and Drug Administration approved Ampyra (dalfampridine) extended release tablets to improve walking in patients with multiple sclerosis (MS). In clinical trials, patients treated with Ampyra had faster walking speeds than those treated with an inactive pill (placebo). This is the first drug approved for this use...Multiple Sclerosis Fri, 22 Jan 2010 01:00:00 PSThttp://mnt.to/f/3wDdhttp://mnt.to/f/3wDdLow vitamin D blood levels are associated with a significantly higher risk of relapse attacks in patients with multiple sclerosis (MS) who develop the disease during childhood, according to a study conducted by researchers from the University of California, San Francisco...Multiple Sclerosis Fri, 22 Jan 2010 01:00:00 PSThttp://mnt.to/f/3wDChttp://mnt.to/f/3wDCThe European Medicines Agency has finalised a review of Tysabri (natalizumab) and the risk of progressive multifocal leukoencephalopathy (PML), a rare brain infection caused by the JC virus. The Agency's Committee for Medicinal Products for Human Use (CHMP) has concluded that the risk of developing PML increases after two years of use of Tysabri although this risk remains low...Multiple Sclerosis Thu, 21 Jan 2010 05:00:00 PSThttp://mnt.to/f/3wCphttp://mnt.to/f/3wCpA new drug for multiple sclerosis promises to change the lives of the 100,000 people in the UK who have the condition, say researchers at Queen Mary, University of London...Multiple Sclerosis Thu, 21 Jan 2010 04:00:00 PSThttp://mnt.to/f/3wBXhttp://mnt.to/f/3wBXClinical trial results for the tablets being developed for multiple sclerosis (MS) will be published in the latest issue of the New England Journal of Medicine. The studies suggest that the oral therapies, potentially the first of their kind for relapsing remitting MS, are at least as effective as current drugs on the market and could be available as early as next year...Multiple Sclerosis Wed, 20 Jan 2010 02:00:00 PSThttp://mnt.to/f/3wwXhttp://mnt.to/f/3wwXFast Forward, LLC, the commercial drug development arm of the National Multiple Sclerosis Society, and the Juvenile Diabetes Research Foundation (JDRF), the leader in research leading to a cure for type 1 diabetes in the world announced a collaborative partnership with Axxam SpA -- a leading company in conducting early-stage discovery research programs for the life science indu...Diabetes Fri, 15 Jan 2010 04:00:00 PSThttp://mnt.to/f/3wp9http://mnt.to/f/3wp9In the February 1st issue of G&D, Dr. Brian Popko (The University of Chicago) and colleagues describe how mutation of a gene called ZFP191 leads to disordered CNS myelination in mice -- reminiscent of what is seen in human multiple sclerosis (MS) patients. The paper will be released online ahead of print at http://www.genesdev.org...Multiple Sclerosis Fri, 15 Jan 2010 01:00:00 PSThttp://mnt.to/f/3wmhhttp://mnt.to/f/3wmhStem cell research in multiple sclerosis (MS) has been given a much-needed shot in the arm thanks to a partnership between the UK's largest charity supporting people affected by the condition and the UK's only charity dedicated to supporting stem cell research...Stem Cell Research Thu, 14 Jan 2010 00:00:00 PSThttp://mnt.to/f/3wgQhttp://mnt.to/f/3wgQScientists at the Gladstone Institute of Neurological Disease (GIND) have identified the reason a key protein plays a major role in two neurodegenerative diseases...Neurology / Neuroscience Wed, 13 Jan 2010 05:00:00 PSThttp://mnt.to/f/3wfvhttp://mnt.to/f/3wfv The New York Times: "The New Jersey Legislature approved a measure on Monday that would make the state the 14th in the nation, but one of the few on the East Coast, to legalize the use of marijuana to help patients with chronic illnesses...Alcohol / Addiction / Illegal Drugs